We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Hsa-miR-217 Inhibits the Proliferation, Migration, and Invasion in Non-small Cell Lung Cancer Cells Via Targeting SIRT1 and P53/KAI1 Signaling.
- Authors
Wenxia Jiang; Likun Hou; Juan Wei; Yifeng Du; Yan Zhao; Xue Deng; Xiangdong Lin
- Abstract
Background: Brain metastasis is a major cause of cancer death in patients with lung cancer. Sirtuin 1 and hsa-miR-217 have been identified to mediate the development of non-small cell lung cancer. Aims: To investigate the roles of hsa-miR-217, its target sirtuin 1, and the P53/KAI1 axis in the brain metastasis from non-small cell lung cancer. Study Design: Cell culture study. Methods: Human pulmonary adenocarcinoma brain metastasis cell line PC-14/B were incubated and treated with constructed lentiviral plasmids expressing miR-217 and/or sirtuin 1. BEAS-2B cell line was used as a control. The targeted regulation of miR-217 to sirtuin 1 was examined using a dual-luciferase reporter assay. Cell proliferation, migration, invasion, and related protein expression were detected to examine the effect of the miR-217/sirtuin 1 expression on metastasis. Results: PC-14/B cells expressed higher sirtuin 1 and lower P53 and KAI1 compared with BEAS-2B control cells (p<0.05). Sirtuin 1 was a direct target of miR-217. MiR-217 expression suppressed PC-14/B cell invasion (p=0.004), migration (p=0.001), and proliferation (p<0.05), whereas sirtuin 1 overexpression reversed all processes. sirtuin 1 expression inhibited P53, KAI1/CD82, matrix metalloproteinase-9, and β-catenin but upregulated E-cadherin protein. MiR-217 overexpression induced reverse changes. Conclusion: Hsa-miR-217 and its target sirtuin 1 acted as metastasis suppressor and promoter gene in non-small cell lung cancer, respectively. The hsa-miR-217/sirtuin 1/P53/KAI1 metastasis regulatory pathway showed novel and crucial roles in brain metastasis from non-small cell lung cancer. This axis might be a potential target for the treatment of brain metastasis of lung cancer.
- Subjects
LUNG cancer prevention; CELL proliferation; ADENOCARCINOMA; ANTIGENS; BIOLOGICAL assay; BRAIN tumors; CANCER invasiveness; CELL culture; CELL lines; CELL motility; CELLULAR signal transduction; CYTOSKELETAL proteins; GENE expression; GLYCOPROTEINS; LUNG cancer; METASTASIS; PLASMIDS; PROTEIN kinases; TRANSFERASES; MICRORNA; MATRIX metalloproteinases
- Publication
Balkan Medical Journal, 2020, Vol 37, Issue 4, p208
- ISSN
2146-3123
- Publication type
Article
- DOI
10.4274/balkanmedj.galenos.2020.2019.9.91